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Summary: Bone morphogenetic proteins (BMPs) have
multiple roles during embryogenesis. Current data indi-
cate that the dosage of BMPs is tightly regulated for nor-
mal development in mice. Since Bmp2 or Bmp4 homozy-
gous mutant mice show early embryonic lethality, we
generated compound heterozygous mice for Bmp2 and
Bmp4 to explore the impact of lowered dosage of these
BMP ligands. Genotyping pups bred between Bmp2 and
Bmp4 heterozygous mice revealed that the ratio of adult
compound heterozygous mice for Bmp2 and Bmp4 is
much lower than expected. During embryogenesis, the
compound heterozygous embryos showed several
abnormalities, including defects in eye formation, body
wall closure defects, and ventricular septal defects (VSD)
in the heart. However, the ratio of the compound hetero-
zygous embryos was the same as expected. Caesarean
sections at E18.5 revealed that half of the compound het-
erozygotes died soon after birth, and the majority of the
dead individuals exhibited VSD. Survivors were able to
grow to adults, but their body weight was significantly
lower than control littermates. They demonstrated pro-
gressive abnormalities in the heart, eventually showing a
branched leaflet in atrioventricular valves. These results
suggest that the dosage of both BMP2 and 4 is critical for
functional heart formation during embryogenesis and af-
ter birth. genesis 47:374–384, 2009. VC 2009 Wiley-Liss, Inc.
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INTRODUCTION
Bone morphogenetic proteins (BMPs) are the members
of the TGF-b superfamily and were found by their osteo-
genic activity when placed in ectopic locations (de Caes-
tecker, 2004; Kishigami and Mishina, 2005). However,
recent studies of several organisms demonstrated that
BMPs have other roles during embryogenesis, including
the dorsoventral and/or anterior-posterior axis formation
and processes of organogenesis, such as cardiac and lung
development (Mishina, 2003; Zhao, 2003). BMP2 and
BMP4 are the first discovered members of the BMP family
and are rediscovered to have these alternate roles. Homo-
zygous mutant embryos for Bmp2 show developmental
abnormalities in fusion of the preammniotic canal at E7.5
and defects in cardiac development and embryonic turn-
ing, and die by E9.5 (Zhang and Bradley, 1996). BMP2 is
necessary for migration but not for induction of neural
crest cells (Correia et al., 2007). It is also necessary for
PGC formation (Ying and Zhao, 2001). Homozygous mu-
tant embryos for Bmp4 show abnormal development in
the posterior half of the embryo and defects in germ cell
development causing death by E10.5 (Lawson et al., 1999;
Winnier et al., 1995; Ying et al., 2001). Severity of the phe-
notype of Bmp4 homozygous mutant embryos varies,
depending partly on genetic background. For example, no
mesoderm induction is observed in a C57BL6 background
but the mutant embryos show a much milder phenotype
in an outbred background and develop an apparent ante-
rior-posterior axis (Furuta and Hogan, 1998; Winnier
et al., 1995). Recent studies using a conditional null allele
revealed important roles of BMP2 and BMP4 in later stages
of embryogenesis. BMP4 is required for the endocardial
epithelial-to-mesenchymal transformation (EMT) in the
atrioventricular canal (AVC) (Jiao et al., 2003) and outflow
Additional Supporting Information may be found in the online version of
this article.
Takashi Uchimura, Yoshihiro Komatsu, and Momo Tanaka contributed
equally to this work.
* Correspondence to: Yuji Mishina, PhD, Department of Biologic and
Materials Sciences, School of Dentistry, University Michigan, 1011 N.
University Ave. 4222A Dental, Ann Arbor, MI 48109-1078.
E-mail: mishina@umich.edu
Contract grant sponsor: Intramural Research Program of the NIEHS/NIH;
Contract grant sponsor: RIKEN Brain Science Institute (to Y.M.)
Published online 23 April 2009 in
Wiley InterScience (www.interscience.wiley.com).
DOI: 10.1002/dvg.20511
' 2009 Wiley-Liss, Inc. genesis 47:374–384 (2009)
tract septation (Liu et al., 2004). BMP4 also plays critical
roles in morphogenesis of lung epithelial cells (Eblaghie
et al., 2006). BMP2 is critical for the formation of the endo-
cardial cushions in the AVC and subsequent endocardial
EMT (Ma et al., 2005; Rivera-Feliciano and Tabin, 2006).
BMP ligands bind to both Type I and Type II receptors
to form heteromultimers for their signal transduction.
Three Type I receptors (BMPRIA, BMPRIB, and ACVRI),
and three Type II receptors (BMPRII, ActRIIA, and
ActRIIB) behave as receptors for BMPs. Homozygous
mutants for Bmpr1a, which encodes a Type I receptor
for BMP2 and BMP4, develop no mesoderm and die by
E8.5 (Mishina et al., 1995). Homozygous mutants for
Bmpr2 also show a phenotype identical to homozygous
mutants for Bmpr1a (Beppu et al., 2000). Homozygous
mutant embryos for Acvr1, which encodes a Type I re-
ceptor for BMP2 and BMP7, start to gastrulate, but stop
developing at the late streak stage of gastrulation (Gu
et al., 1999; Komatsu et al., 2007; Mishina et al., 1999).
The fact that homozygous mutants for BMP receptors
show more severe phenotypes than their ligands
prompted us to hypothesize that loss of Bmp2 may be
compensated, in part, by BMP4, and loss of Bmp4 may
be compensated by BMP2. Both genes are highly con-
served with over 90% similarity in the mature proteins,
thus it is reasonable to hypothesize that Bmp2 and
Bmp4 may play synergistic roles for proper embryonic
development, and generation of compound mutant
embryos may further reveal functions of these genes.
The amount of BMP signaling is regulated at different
levels. Recent findings demonstrated that extracellular
antagonists including noggin and chordin tightly regulate
the amount of signaling (Balemans and Van Hul, 2002;
Yanagita, 2005). Indeed, compound mutant embryos of
noggin and chordin display a wide range of severity in
their phenotype depending on the numbers of functional
copies of BMP antagonists (Anderson et al., 2002; Bachiller
et al., 2000), suggesting that tight regulation of the
amount of BMP signaling is critical for normal develop-
ment. It is reported that a small portion of heterozygous
mutant mice for Bmp4 in a C57BL6 background demon-
strate some phenotypes including polydactyl, a shorter
head, and circling behavior (Dunn et al., 1997), but their
survivability was not affected. A hypomorphic allele for
Bmp4 was recently reported (Goldman et al., 2006). It
was generated by introduction of a mutation in the cleav-
age site of the BMP4 precursor. Analyses of mice homozy-
gous for this mutation revealed that the proper amount of
BMP4 is critical for placental vasculature formation and
ventral body wall closure (Goldman et al., 2006). No het-
erozygous phenotype was reported originally for Bmp2
(Zhang and Bradley, 1996), however, we recently found
that some heterozygous embryos for Bmp2 exhibited clo-
sure defects in the cephalic region of the neural tube
(Castranio and Mishina, 2008). Also, we recently gener-
ated a floxed allele for Bmp2 and the presence of a neo
selection cassette in the locus dramatically reduced levels
of Bmp2 (Singh et al., 2008). This leads to closure defects
in cephalic region of the neural tube as well as in the ven-
tral body wall (Singh et al., 2008). Therefore, it would be a
reasonable hypothesis that mice that are compound heter-
ozygous mutant for Bmp2 and Bmp4 would develop addi-
tional phenotypes during development.
Here, we found that compound heterozygous mutant
mice for Bmp2 and Bmp4 were underrepresented at the
time of weaning. Approximately half of the compound
heterozygous fetuses showed defects in formation of the
interventricular septum (ventricular septal defects, VSD)
during development and died soon after birth. A small
portion of the compound heterozygous fetuses showed
a variety of phenotypes including closure defects in the
ventral abdominal body wall, suggesting that those
organs are sensitive for a decreased dose of BMPs during
development. Interestingly, the survivors progressively
developed abnormal valve structure in the heart by 2
months after birth. These results suggest that the dosage
of both of BMP2 and 4 is critical for functional heart for-
mation during embryogenesis and after birth, and that
lowered BMP signaling is a potential cause of congenital
and postnatal heart abnormalities such as VSD.
RESULTS
Bmp2/Bmp4 Compound Heterozygotes Show
Disadvantage for Survival
First, we set up matings between Bmp2 heterozygous
and Bmp4 heterozygous mice, which had a mixed
genetic background of 129SvEv and C57BL6. In this
combination, 25% of pups should be compound hetero-
zygotes for Bmp2 and Bmp4 (Bmp21/2;Bmp41/2).
However, genotyping after the weaning stage revealed
that only 10.6% of pups out of 415 mice were com-
pound heterozygotes, whereas the other genotypes
were in reasonable numbers (36.3% for wild type, 29.2%
for Bmp4 single het, 23.9% for Bmp2 single het). These
survived compound heterozygotes were smaller than lit-
termates in both sexes at 3 weeks (Fig. 1, total 89 males
and 94 females). The relative body weight of the sur-
vived compound heterozygous males and females to
wild-type males and females were 68% and 59%, respec-
tively (see Fig. 1). Swapping the genotypes of parents
did not cause any overt changes in the ratio and body
weight of compound heterozygotes (data not shown).
Since both Bmp4 null and Bmp2 null embryos die in
early stages of development, we speculated that com-
pound heterozygotes might demonstrate an embryonic
phenotype either similar to these nulls or something
unique. Results of timed mating revealed that we recov-
ered expected ratios of compound heterozygotes during
mid to late gestation, suggesting that compound hetero-
zygotes were able to survive much longer than homo-
zygous null embryos for each gene. Some of the com-
pound heterozygotes developed interesting phenotypes
depicted in Figure 2. They showed severe edema as early
as E13.5 (2 out of 36 at E13.5, Fig. 2c,k,l) suggesting
defects in heart function. Some others showed eye defects
(7 out of 73 at E13.5-E15.5, Fig. 2d,k) or body wall closure
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FIG. 1. Body weight of 3-week-old mice. Mixed background (left) and 129SvEV background (right). Black bar, male; white bar, female; WT;
wild type, B2H, Bmp2 heterozygous mice, B4H, Bmp4 heterozygous mice, B2HB4H, compound heterozygous mice for Bmp2 and Bmp4.
Numbers of animals measured are shown underneath of each bar. B2HB4H mice are smaller in their body weight than other genotype in
both sexes (P < 0.0001).
FIG. 2. Abnormalities developed in the compound heterozygous embryos. Whole view of mouse embryos at E13.5 (a–d and i–l), E15.5 (e–
h), wild type (a, e, i, and j), and compound heterozygous (b–d, f–h, and k, l) embryos. Compound heterozygous embryos showed no signifi-
cant abnormality (b and f), edema (c and k, l, white arrowheads), small eye (d and k, l), and hernia (g and h, asterisk). i and j, and k and l are
the same embryo, respectively. Scale bar, 1 mm. [Color figure can be viewed in the online issue, which is available at www.interscience.
wiley.com.]
defects that lead to hernia (7 out of 73 at E13.5-E15.5, Fig.
2g,h, asterisk). However, the majority of compound het-
erozygotes in these stages were grossly normal (55 out of
73 at E13.5-E15.5, depicted in Fig. 2b,f), as well as all of
the wild type or single heterozygous mutant embryos for
each gene (except small portion of Bmp2 heterozygous
embryos, see below). These results indicated that severe
edema or body wall closure defects were not the only
cause of the shortage of compound heterozygotes by the
time of weaning. Ratios of compound heterozygotes were
relatively normal in mid/late gestation (Table 1), indicating
that the majority of compound heterozygotes can survive
to late gestation, which excludes the possibility that the
majority of them die earlier. Since previous studies have
indicated the importance of BMP signaling in heart devel-
opment, and a small number of the embryos showed
edema as shown in Figure 2, we hypothesized that abnor-
malities that develop in the heart of compound heterozy-
gous embryos would compromise their survivability dur-
ing the perinatal period.
Histological observation revealed that some of the com-
pound heterozygous mutant embryos developed micro-
phthalmia (see Fig. 3). The particular compound embryo
shown in Figure 3 had smaller a left eye than that of wild
type (mild form of microphthalmia), whereas the right eye
showed severe microphthalmia characterized by lens rem-
nant, corneal-conjuntival epithelium, and double-layered
retinal pigment epithelium. These results suggest that the
retina started to degenerate soon after its formation and
was subsequently replaced by the retinal pigment (inner
layer of pigmented epithelium) (Fig. 3f).
We previously noticed that a small portion of hetero-
zygous embryos for Bmp2 develop neural tube closure
defects especially in the cephalic region (Castranio and
Mishina, 2008). The frequency of the neural tube defects
was not increased by addition of Bmp4 heterozygosity
to the Bmp2 heterozygous null background (6 out of 41
embryos for Bmp2 heterozygous embryos and 4 out of
42 embryos for Bmp2/Bmp4 compound heterozygous
embryos) suggesting that dosage of BMP4 has less of an
impact on developing the neural closure phenotype
than that of BMP2.
Compound Heterozygotes Show Developmental
Abnormalities in Heart
Histological observation of the E13.5 heart revealed
that wild-type embryos are about to fuse the interven-
Table 1
Ratio of Genotyping of Offspring From the Breeding Between Bmp2 het and Bmp4 het
Stage Wild type (%) Bmp2 het (%) Bmp4 het (%) Compound het (%) Total Resorption site
E13.5 18 (15.4) 37 (31.6) 25 (21.4) 36 (30.8) 117 6
E14.5 9 (20.5) 9 (20.5) 12 (27.3) 14 (31.8) 44 21
E15.5 26 (25.0) 27 (26.0) 28 (26.9) 23 (22.1) 104 25
E18.5 23 (28.4) 18 (22.2) 19 (23.4) 21 (35.9) 81 9
3 wk 129 (39.8) 80 (24.7) 86 (26.5) 29 (9.0) 324 n/a
FIG. 3. Histological observation of eye abnormalities. H&E staining of head sections at E13.5. Wild type (a–c) and compound heterozygous
(d–f) embryos are shown. The compound heterozygous mutant showed mild (e) and severe (f) forms of microphthalmia. L, lens; asterisk,
remnant of lens; arrows, presumptive corneal-conjunctival epithelium; white arrowhead, degenerated retina replaced by pigment. Scale bar,
500 lm (a, d), 100 lm (b, c, e, f).
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tricular septum to the top portion of cardiac wall (2/4
are fused, 2/4 are not, Fig. 4a–d). In the case of com-
pound heterozygous mice, 6 out of 6 showed ventricular
septal defects (VSD) (Fig. 4e–h). To distinguish if this as
a persistent defect or a delay of fusion, we next made
histological observations at E15.5. At this stage, the sep-
tum in nearly all of wild type (13/14) and in all of both
single heterozygous embryos examined were fused,
whereas the majority of the compound heterozygous
embryos still showed VSD (12/16) (Fig. 4m-t).
FIG. 4. Heart abnormalities developed in compound heterozygous embryos. H&E staining of heart sections at E13.5 (a–h) and E15.5 (i–t).
At E13.5, ventricular septum started to close in wild type (a and b), Bmp2 heterozygous (c), Bmp4 heterozygous (d) embryos, but in the com-
pound heterozygous embryos, all of ventricular septum have not closed yet (e–h, asterisks). Two examples for WT and three examples for
the compound heterozygotes are shown. At E15.5, all ventricular septum are completely closed in wild type (i–k; sequential with 35 lm inter-
val, l; magnified image of j). In the compound heterozygous embryos the ventricular septum has not closed (asterisks, m–o; sequential
images with 35 lm interval, p; magnified image of a region in n, q–s; sequential images with 35 lm interval, t; magnified image of a region in
r). Two examples are shown. Scale bar, 500 lm (a–g); 200 lm (h); 250 lm (j–k, m–o, q–r); 100 lm (l, p, and t).
Table 2
Results of C-Section
Genotype Total Infrequent breath (%) Dead (%) Body weight (mg) average (STD)
Wild type 23 2 (8.7) 0 (0) 1,143.0 (120.5)
Bmp2 Het 18 1 (5.6) 1 (5.6) 1,162.5 (87.7)
Bmp4 Het 19 1 (5.3) 1 (5.3) 1,137.2 (191.4)
Compound Het 21 12 (57.1)** 11 (52.3)** 993.1 (111.0)*
Total 81 16 (19.8) 15 (18.5) 1,107.1 (147.1)
*P < 0.001, Student t-test.
**P < 0.001 to Bmp2 Het or Bmp4 Het, Fisher’s exact test.
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Since the ratio of the compound heterozygotes is rela-
tively normal in mid/late gestation (Table 1), and we
observed little death of pups during lactation period, we
speculated that some of the compound heterozygotes
die immediately after birth. E18.5 embryos were recov-
ered from pregnant females by C-section and were eval-
uated for their ability to survive. All pups started to
breathe, however, about half of compound heterozy-
gotes showed respiratory difficulties, and died within
30 minutes (Table 2). Compound heterozygotes were
smaller than other types of pups (P < 0.001). Among
compound heterozygotes, the ones that died had lower
body weights than survivors in body weight (949 mg 6
10.6 vs. 1042 mg 6 9.6 mg, respectively, P < 0.005). Ex-
amination of heart histology revealed a very clear con-
trast. The majority of compound heterozygotes that sur-
vived after C-section showed a relatively normal heart
histology (4/5), including complete formation of the
interventricular septum (Fig. 5c,d). Interestingly, all
of the compound heterozygotes that died within 30
minutes after C-section showed VSD (Fig. 5e,f). This
result suggests that perinatal death is probably due to
heart malfunction caused by VSD because we did not
see any overt changes in the lung (see below). Other
types of abnormalities including atrial septal defects
(ASD), double outlet right ventricle (DORV), and persis-
tent truncus arteriosus (PTA) were not observed in the
compound heterozygous mutant pups (Supporting Infor-
mation Fig. 1 and data not shown).
We examined levels of several markers including
MSX2, a known downstream target of BMP signals
(Brugger et al., 2004) and SOX9, a marker for neural
crest derivatives that populate atrioventricular cushions
(Nie et al., 2008), but no overt changes were observed
between wild type and the compound heterozygous
heart (Supporting Information Fig. 2).
To understand the effects of lowered BMP signaling
on heart development after birth, we made histological
observations on 3-week-old hearts. The heart wall
seemed normal (Fig. 6a,d,g), but leaflets in the tricuspid
valve and mitral valve in hearts of compound heterozy-
gotes showed abnormal morphology (Fig. 6e,h, and Fig.
6f,i, respectively). They were prolonged and more prom-
inent in particular when body weight was low. These
defects were not obvious in C-sectioned samples at
E18.5 (Fig. 5 and data not shown) suggesting that these
defects are developed postnatally. Histological observa-
tion of 2-month and 4-month-old hearts showed more
dramatic changes in valve form. They were elongated
and branched (Fig. 6o,q,r, n 5 4 for control and com-
pound heterozygous mutants). No abnormalities were
found in single heterozygous mutant mice for either for
Bmp2 or Bmp4.
No Overt Abnormalities are Found in Lung
Since half of compound heterozygotes fail to initiate
continuous breathing, we also examined the histology of
the lungs. At E15.5, there were no overt morphological
changes (Supporting Information Fig. 3a,b). However, at
3 weeks, the color of lungs in compound heterozygotes
was pale compared with that in control (Supporting In-
formation Fig. 3c,d). The histology of lungs at the time
of C-section revealed less alveolar spaces in compound
heterozygotes (Supporting Information Fig. 3e–l), how-
ever, the changes were minimal. Three-week-old samples
showed the similar tendency, lower numbers of alveolar
vesicles (Supporting Information Fig. 3m–p); however,
the thickness of the epithelial layer of bronchioles was
comparable. SP-C and CC10, markers for alveoli epithe-
lium, were produced in both control and compound het-
erozygous mutant lung in comparable manners (Sup-
porting Information Fig. 4).
Genetic Background Affects Severity
of the Phenotypes
Because the genetic background of the mice used
were a mixture of 129SvEv and C57BL6, variability of
the phenotypes might be explained by variability of
genetic background. In fact, it is reported that pheno-
types of Bmp4 null embryos change in different
FIG. 5. Defects in heart septation in the compound heterozygous
mutants at E18.5. Fetuses were recovered at E18.5 by C-section
and breathing was initiated by mild stimuli. Histological sections of
heart were stained with H&E. Wild type (a and b) and majority of the
compound heterozygous pups that revived after C-section (c and d,
four of five) showed no evidence of VSD. Compound heterozygous
mutants that did not revive showed VSD (e and f, asterisks, six of
eight). Two examples for each case are shown. Scale bar, 500 lm.
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FIG. 6. Valve abnormalities in the compound heterozygous mutant pups. Heart sections including atrioventricular valves from 3-week-old
pups (a–i) and from adults (4 months for j–o and 2 months for p–r) were stained with Masson’s trichrome. Wild type (a–c, j–k) and two exam-
ples of compound heterozygous pups (d–f, g–i, m–o, p–r) are shown for each stage. Magnified images of right (tricuspid) and left (mitral)
atrioventricular valves are shown in b, e, h, k, n and q and c, f, i, l, o, and r, respectively. h is a magnified image from an adjacent of g. Blue
staining indicates atrioventricular valves. An arrow indicates branched atrio-ventricular valve (h, o, q, r). Scale bar, 1 mm (a, d, g, j, m, and p);
100 lm (b, c, e, f, h, i, k, l, n, o, q, and r).
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backgrounds. In an outbred background, homozygous
null embryos can survive longer and reach the organo-
genesis stages whereas in a C57BL6 background, their
phenotype resembles Bmpr1a or Bmpr2 null mutant
embryos (Furuta and Hogan, 1998; Winnier et al., 1995).
Phenotypes of Bmp4 heterozygous mutants are also
affected by genetic background. In a C57BL6 back-
ground, small proportions of heterozygous mutant mice
show minor abnormalities including an extra digit and
circling behavior (Dunn et al., 1997). We previously
noticed that Bmp2 heterozygous mutants in a C57BL6
background showed closure defects in the cephalic neu-
ral tube more frequently than heterozygous mutants in a
mixed background of 129SvEv and C57BL6 (Castranio
and Mishina, 2008). These facts suggest that the genetic
background influences the severity of the phenotypes.
To address this issue, we generated compound heterozy-
gous mutants in a 129SvEv background and in a C57BL6
congenic background. For the latter case, we back-
crossed heterozygous mice to C57BL6 more than seven
times (expected ratio of C57 is over 99%). In mid-to-late
gestation, a ratio of the compound heterozygotes was
the same as expected (approximately 25%) (Table 3). A
total of 307 pups in a 129SvEv background were geno-
typed at 3 weeks after birth and an under representation
of compound heterozygotes were observed (Table 3).
Like in mixed background, compound heterozygotes
were smaller than wild type or heterozygotes for each
gene [Fig. 1, the relative body weight of the survived
compound heterozygotes to wild type was 53% (male)
or 62% (female)]. In contrast, at 3 weeks none of the
over 80 pups in a C57BL6 background were compound
heterozygotes, suggesting that they died during the peri-
natal period due to severe defects caused by the genetic
background (Table 3). These results also may suggest
that genetic modifiers in the C57BL6 background may
account, at least in part, for the variable phenotypes of
compound heterozygous mutants found in the mixed
genetic background.
DISCUSSION
Dosage of BMP Signaling and Related Phenotype
We used a genetic approach to partially reduce the
levels of BMP signaling and found that a proper dosage
of BMP2 and BMP4 is critical for several aspects of nor-
mal development including functional heart formation.
Most of the compound heterozygous individuals that
died during the perinatal period showed ventricular sep-
tal defects, which might affect the initiation and continu-
ation of breathing. Several reports using conditional and
hypomorphic alleles of BMP ligands, receptors, and sig-
naling molecules have demonstrated that BMPs play crit-
ical roles during heart development, including septation
in the outflow tracts, proliferation of the heart wall, and
EMT in the atrial-ventricular cushion (Delot et al., 2003;
Gaussin et al., 2002, 2005 Jiao et al., 2003; Kaartinen
et al., 2004; Kim et al., 2001; Liu et al., 2004; Ma et al.,
2005; Nie et al., 2008; Park et al., 2006; Rivera-Feliciano
and Tabin, 2006; Stottmann et al., 2004; Stroud et al.,
2007; Wang et al., 2005). Histological observations of
the compound heterozygous mutants described here
suggest that proper formation of the interventricular
septum may be the most sensitive process affected by
the reduced levels of BMP signaling. Bmp2 is highly
expressed in the atrioventricular canal myocardium
between E11.5 and E14.5, and also expressed in endo-
cardial cushion from E12.5 (Abdelwahid et al., 2001).
Bmp4 is highly expressed in outflow tract myocardium
and endocardial cushion (Abdelwahid et al., 2001).
Bmpr1a is expressed nearly ubiquitously in the develop-
ing stage of the heart whereas Bmpr1b expression in
the heart is very low (Dewulf et al., 1995). These expres-
sion patterns suggest that BMP2 and BMP4 produced in
endocardial cushion signals through BMPRIA to play a
role for fusion of interventricular septum to endocardial
cushion. These facts also suggest that BMP2 and BMP4
play roles for morphological integrity of the tricuspid
and mitral valves that are developed from atrioventricu-
lar canal.
A closure defect in the posterior ventral body wall is
another dosage sensitive process. It has a nearly identical
phenotype of that found in the conditional mutant
embryos of Bmpr1a induced by Dermo1-Cre (Sun et al.,
2007). Double homozygous mutations of Msx1 and
Msx2 show a similar omphalecele phenotype (Ogi et al.,
2005) suggesting that during mid-gestation, both BMP2
and BMP4 work together to maintain a sufficient level of
BMP signaling through BMPRIA to regulate levels of
Msx1 and Msx2. Some of the compound heterozygous
embryos for Bmp2 and Bmp4 developed hypomorphic
eyes, which would be a similar phenotype to that caused
by a retina-specific disruption of Bmpr1a in Bmpr1b
null background (Murali et al., 2005). In this case,
proliferation of the cells in the retinal neuroectoderm is
Table 3
Ratio of Genotyping of Offspring in Different Genetic Background
Strain Stage Wild type (%) Bmp2 het (%) Bmp4 het (%) Compound het (%) Total
Mixture E15.5 26 (25.0) 27 (26.0) 28 (26.9) 23 (22.1) 104
129SvEv E15–16 12 (25.1) 16 (28.5) 14 (25.0) 14 (25.0) 56
C57BL6 E15–16 24 (40.0) 13 (21.7) 13 (21.7) 10 (16.7) 60
Mixture 3 wk 129 (39.8) 80 (24.7) 86 (26.5) 29 (9.0) 324
129SvEv 3 wk 98 (31.9) 92 (30.0) 99 (32.2) 18 (5.9) 307
C57BL6 3 wk 36 (42.4) 25 (29.4) 24 (28.2) 0 (0.0) 85
Results from E15.5 were shown for mixed background. Results from E15.5 and E16.5 were combined for 129SvEv and C57BL6.
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drastically reduced at E11.5. Interestingly, no overt phe-
notype is observed if Bmpr1b allele is wild type (Murali
et al., 2005). These suggest that BMP2 and BMP4 work
together to send signaling through both BMPRIA and
BMPRIB for proper retinal development during mid-
gestation.
Some of the Bmp2 heterozygous mutant embryos de-
velop closure defects in the cephalic neural tube leading
to perinatal death (Castranio and Mishina, 2008). Inter-
estingly, the ratio of heterozygous mutant embryos dem-
onstrating the neural tube defects is altered depending
on their genetic background. We recently generated a
hypomorphic allele for Bmp2 by knocking in a polII-neo
cassette, of which expression level was 10% compared
with a wild-type allele, and embryos having the hypo-
morphic allele over the null allele showed higher fre-
quency of the neural tube defects (Singh et al., 2008).
However, as described in the Result section, the fre-
quency of the neural tube defects in the compound het-
erozygous embryos for Bmp2 and Bmp4 was not
increased compared with that in Bmp2 heterozygous
embryos. Although small proportions of Bmp4 heterozy-
gous mutant mice show abnormalities, no perinatal
death is reported in both inbred (congenic) and mixed
background (Dunn et al., 1997) (unpublished observa-
tion). We have dissected over 500 heterozygous embryos
for Bmp4 in various genetic backgrounds but never
found neural tube closure defects in this genotype (data
not shown). Together, the data suggest that dosage of
BMP2, but not BMP4, would be of primary importance
for development of neural tube closure defects in the ce-
phalic region. Generation of a hypomorphic allele for
Bmp4, by introducing a mutation in the cleavage site for
maturation is previously reported (Goldman et al.,
2006). It would be an interesting future experiment to
further reduce the amount of BMP2 and BMP4 by com-
bining these hypomorphic alleles to uncover relatively
less sensitive biological processes, which may include
limb bud formation and subsequent digit specification.
Potential Interactions of BMP Ligands
for Their Functions
Several reports demonstrate that compound homozy-
gous mutants reveal overlapping functions of BMP
ligands. For example, double homozygous null embryos
for Bmp5 and Bmp7 die by E10.5 even though the
impact of the loss of one of these genes for proper
embryogenesis is negligible (Solloway and Robertson,
1999). Double homozygous null embryos for Bmp6 and
Bmp7 show similar defects in interventricular septation
as we have shown in this article (Kim et al., 2001).
These results suggest that some of the BMPs share redun-
dant functions especially in the tissues where they are
co-expressed. Compound heterozygous mutant mice for
Bmp4 and Bmp7 showed an abnormal skeletal pheno-
type, which also suggests that dosage of BMP signaling
may play a role in the morphology of bones (Katagiri
et al., 1998).
It is reported that heterodimer molecules for BMPs
may have functions distinct from their homodimers. In
frog, purified BMP4/7 heterodimer has a potent meso-
derm inductive ability compared with a mixture of
BMP4 homodimer and BMP7 homodimer (Suzuki et al.,
1997). In cell culture and in vivo bone defect models,
BMP2/7 heterodimer shows a more potent ability for
induction of alkaline phosphatase and differentiation to-
ward osteoblast lineages (Koh et al., 2008; Tsuji et al.,
1998; Zhu et al., 2006). In Drosophila, Screw-Dpp heter-
odimers shows potent activity for specification of dorsal
tissues (Shimmi et al., 2005). Although these are the
examples of heterodimers between the Dpp subgroup
(BMP2, BMP4) and the 60A subgroup (BMP5, BMP6,
BMP7), these facts suggest BMP2/4 heterodimer may
also have unique functions. It is an alternative possibility
that an alteration of the amount of heterodimers for
BMP2and BMP4 may be a cause of the abnormalities
reported here. A knock-in experiment of Bmp2 gene
into the Bmp4 locus (or vice versa) may shed light on
this possibility.
BMP Dose and Heart Functions
Most of the surviving compound heterozygous
mutants can live for over a year, but the majority are
smaller in body size (weight and statue). One of the
interesting possibilities for smaller body size would be
insufficient circulation. Since wall thickness of heart
chambers in the compound heterozygous mutants are
seemingly thinner than that of control at neonatal stage
(see Fig. 5), it is possible to speculate that ejection vol-
ume in the mutants could be smaller. An alternative pos-
sibility is that insufficient circulation is caused by the
abnormal morphology of valve leaflets, as they age (see
Fig. 6). Atrioventricular cushion-specific disruption of
Bmpr1a causes defects in leaflet formation in both mis-
tral and tricaspid valves, which in turn leads to higher
blood pressure in the atrium (Gaussin et al., 2005;
Stroud et al., 2007). Thus, we speculate that reduction
of BMP2 and/or BMP4 signaling through BMPRIA in the
valves would be one of the causes of morphological
abnormalities found in human cases. It is reported that
cell proliferation in heart valves stops 1 week after birth
(Kruithof et al., 2007). There is no overt difference in
proliferative ability of cells in valves at E18.5 and 1 week
after birth (data not shown), suggesting BMP signaling
may be important for morphological changes of the cells
in the valves during postnatal development. It will be of
interest in the future to assess functionality of the heart
of survived compound heterozygotes because it is
expected that abnormal valve structure may interfere
with blood flow from atriums to ventricles.
MATERIALS AND METHODS
Mouse
Generation and characterization of mutant mouse
strains were described elsewhere (Winnier et al., 1995;
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Zhang and Bradley, 1996). All mouse experiments were
performed in accordance with NIEHS/NIH guidelines
covering the humane care and use of animals in
research.
PCR Genotyping
Mouse genotypes were initially determined by South-
ern blot described elsewhere (Winnier et al., 1995;
Zhang and Bradley, 1996). Subsequently, each allele was
identified by PCR using the following primers. For
Bmp2, primer 1, 50-AGCATGAACCCTCATGTGTTGG-30;
primer 2, 50-GTGACATTAGGCTGCTGTAGCA-30; primer
3, 50-GAGACTAGTGAGACGTGCTACT-30. For Bmp4,
primer 4, 50-TTGATCTTTCGGACCTGTTTTA-30; primer 5,
50-ACGACCATCAGCATTCGG-30; primer 6, 50-GAATTCGC
CAATGACAAGAC-30.
Histology
Embryos were fixed in 4% paraformaldehyde, embed-
ded in paraffin, and stained with Hematoxylin and Eosin
(H&E). Some sections from adult heart were stained
with Masson’s trichrome to visualize collagen fibers.
Immunohistochemistry
Immunohistochemistry was performed by standard
procedures. Briefly, 6 lm paraffin sections were sub-
jected to antigen retrieval (10 mM citrate buffer, pH 6.0
with microwave treatment for 10 minutes) and subse-
quently incubated with anti-SOX9 (H-90, Santa Cruz),
anti-MSX2 (M1069, Sigma), anti-SP-C (AB3428, Milli-
pore), or anti-CC10 (T-18, Santa Cruz) with dilution of 1/
10-1/100 at 48C for overnight. Either HRP conjugated or
Alexa fluor-488 labeled secondary antibodies were used
for detection.
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